STERO Biotechs is a biotechnology company engaged in the research and development of cannabidiol (CBD)-based treatment solutions. It develops ST-101, a product that is is targeted for steroid sparing in multiple indications. STERO's main focus is aimed at inflammatory bowel diseases (IBD) and steroid-dependent Crohn’s disease.
|HQ||Bnei Brak, IL||Map|
|Employees (est.) (Mar 2020)||7|
When was STERO Biotechs founded?
STERO Biotechs was founded in 2017.
Who are STERO Biotechs key executives?
STERO Biotechs's key executives are David Bassa, Ofer Alshech and Guy Defrin.
How many employees does STERO Biotechs have?
STERO Biotechs has 7 employees.
Who are STERO Biotechs competitors?
Competitors of STERO Biotechs include Kaleidoscope Labs, CBGenius and FSD Pharma.
Where is STERO Biotechs headquarters?
STERO Biotechs headquarters is located at Barukh Hirsch St 14, Bnei Brak, Bnei Brak.
Where are STERO Biotechs offices?
STERO Biotechs has an office in Bnei Brak.
How many offices does STERO Biotechs have?
STERO Biotechs has 1 office.
Receive alerts for 300+ data fields across thousands of companies